Pfizer Inc. (PFE) is a multinational pharmaceutical and biotechnology company headquartered in New York City. It researches, develops, and manufactures biopharmaceutical products across a range of dif...
Tag: Pfizer
Pfizer: Is It a Good Investment in the Long Term?
Pfizer is known for increasing its dividend for 11 years; projected earnings estimate its ratio to rise to 32.92%. The chart shows strong buying pressure with a healthy and necessary retracement. The...
More Than One Million May Die In China From Covid Through 2023 – Report
Pedestrians wearing face shields in Beijing, China, on Thursday, Dec. 15, 2022. China’s economic … [+] activity worsened in November before the government abruptly dropped its Covid Zero p...
China ADRs To Climb The Great Wall Of Worry As PCAOB Resets HFCAA Clock, Week In Review
China Last Night KraneShares Week in Review Asian equity markets had a mixed performance week as the PCAOB announced breaking news, Pfizer’s COVID treatment was approved, and The Central Economi...
Pfizer and Moderna Shares Break Out. Here’s the Trade.
Drug stocks have been on fire lately, and over the past few weeks, the two leading covid-19 vaccine makers, Pfizer (PFE) – Get Free Report and Moderna (MRNA) – Get Free Report, have surg...
Pfizer to Sell Paxlovid in China as Covid Cases Surge
(Bloomberg) — Pfizer Inc. cemented a deal first announced in March to sell its antiviral medication Paxlovid in China through a state-owned company, adding to supply of Covid treatments in the c...
Will Potential Revenue of $10-$15 Billion by 2030 Push Pfizer Stock Price Towards $100 Mark?
Pfizer’s share price reclaimed another bullish hurdle. Technical indicators suggest a positive trend in the valuation. In Tuesday’s letter on December 13, the NYSE: PFIZER stock price (PFE) opened a g...
Pfizer’s Paxlovid Approved In China, State Council Emphasizes Domestic Consumption
China Last Night KraneShares Key News Asian equities were higher following yesterday’s lighter-than-anticipated US CPI print (sarcastically, only 7.1%!) though volumes were light in advance of today’s...
Pfizer Stock to Enjoy Investment in Manufacturing Facility
The pharmaceutical giant Pfizer Inc. (NYSE:PFE) has recently gone through several updates that are likely to make an impact over the stock price. Recently the company announced an investment of about ...
FDA to decide on Pfizer vaccine for older adults by May 2023
The Food and Drug Administration is expected to decide by spring whether to approve Pfizer’s vaccine to prevent respiratory syncytial virus, or RSV, in adults ages 60 and older. Pfizer, in a sta...
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history
Pfizer has rejected allegations made by rival Moderna that its Covid-19 vaccine is a copy, accusing the Boston biotech company of rewriting history to lay claim to technology developed by a field of s...
8 dividend hikes to watch for this week: Pfizer, Union Pacific
Companies often establish a pattern of hiking dividends at the same time each year, giving investors a reliable cash influx and enticing them to stick around for the long term. With help from StreetIn...
Pfizer Stock Price Rose Despite a Decrease in COVID Cases, How?
No Result View All Result © Copyright 2022. The Coin Republic Are you sure want to unlock this post? Unlock left : 0 Yes No Are you sure want to cancel subscription? Yes No Source: https://www.thecoin...
Stock Market Looks Poised to Rally as Bond Yield Falls
Text size Michael Nagle/Bloomberg The worst may be over for the stock market. Key equity indexes continued their autumn rally, and there could be more gains before the end of the year, helped by conti...
Pfizer says omicron booster is better against new subvariants like BQ.1.1
A staff member draws up a syringe with the Comirnaty vaccine from Biontech and Pfizer adapted to the Omicron-BA.1 variant at the Mainz vaccination center. Sebastian Christoph Gollnow | dpa | Picture A...
Pfizer A Top 25 Dividend Giant With 3.29% Yield
Pfizer has been named as a Top 25 ”Dividend Giant” by ETF Channel, with a staggering $34.47B worth of stock held by ETFs, and above-average ”DividendRank” statistics including ...
Pfizer Stock’s Post-Covid Future Looks Healthy
These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...
Pfizer releases data showing omicron boosters are better than old shots
A health worker administers a dose of Pfizer covid-19 vaccine to a man at the Sanford Civic Center. With the emergence of the Omicron covid-19 variant in numerous countries, including the United State...
GM, Pfizer, Audi Pull Ads From Twitter After Musk Sale—Here Are The Other Companies Rethinking Their Ties
Topline Twitter owner Elon Musk’s plan to right the social media company’s financial ship while also loosening its content moderation rules could face early headwinds, with several large c...
Pfizer Stock Surges On Trifecta Of Good News As Earnings Beat, Guidance Boosted
Pfizer stock hit a trifecta Tuesday after the company followed a beat-and-raise earnings report with promising results for a respiratory vaccine in unborn children. X The vaccine is administered to pr...
Pfizer CEO reveals growth plan as company faces up to $18 billion revenue hit
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmac...
Abiomed, Uber, SoFi, Pfizer and more
Take a look at some of the biggest movers in the premarket: Abiomed (ABMD) – Abiomed stock soared 51.6% in premarket trading after agreeing to be acquired by Johnson & Johnson (JNJ) in a nearly $1...
Pfizer, Qualcomm, CVS, Peloton, Coinbase, Uber
(Bloomberg) — Disappointing earnings from tech giants this week exposed their vulnerability to a slowing economy: Alphabet and Meta Platforms were battered by softness in digital advertising, ec...
Pfizer just announced plans to sell its COVID-19 vaccine for at least $110 a dose in 2023 — that’s a markup of about 10,000%
Pfizer just announced plans to sell its COVID-19 vaccine for at least $110 a dose in 2023 — that’s a markup of about 10,000% If you plan on getting boosted against COVID-19 this winter, then yo...
Pfizer CEO Shares Companies Future Plans, Surely Affecting PFE Stock Price
Pfizer emerged as a prominent name as producer of Covid-19 vaccines and PFE stocks reflected good growth American multinational pharmaceutical company Pfizer (PFE) has new plans to diversify its produ...
Moderna Stock Takes Off on Cancer Vaccine News
Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck (ticker: MRK) will pay Moderna (MRNA) $250 million for...